Current Prices from Benitec Biopharma Inc. - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	BNTC	USD	12.06.2025 23:18	15,13 USD	16,59 USD -8,80 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
0,00 %	-5,32 %	13,57 %	5,99 %	23,41 %	102,54 %	-88,47 %

Company Profile for Benitec Biopharma Inc. - Common Stock Depository Receipt

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Company Data

Name Benitec Biopharma Inc. - Common Stock

Company Benitec Biopharma Inc.

Symbol BNTC

Website https://benitec.com

Primary Exchange

NASDAQ

ISIN US08205P2092

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Dr. Jerel A. Banks M.D., Ph.D.

Market Capitalization 351 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 3940 Trust Way, 94545 Hayward

IPO Date 2014-06-24

Dividends from 'Benitec Biopharma Inc. - Common Stock'

Ex-Date	Dividend per Share
01.06.2018	0,003 USD

ID Changes

Date	From	To
18.08.2015	BTEBY	BNTC

Ticker Symbols

Name	Symbol
NASDAQ	BNTC

More Shares

Investors who Benitec Biopharma Inc. - Common Stock hold also have the following shares in their portfolio:

NSTS Bancorp, Inc. - Common Stock Share

ZEEKR Intelligent Technology Holding Limited American Depositary Shares (each representing ten (10) Ordinary Shares) Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog